Patent application EP20167507A (EP), filed 2020-04-01
Publication number: EP3718541A1
Title: METHODS AND COMPOSITIONS FOR TREATMENT OF ANXIETY IN ANIMALS
Abstract: [0001]    The present technology relates to a method for treating anxiety or an anxiety-related disorder in an animal subject, the method comprising administering an effective amount of cannabidiol (CBD) to the animal subject.
IPC codes: A61K  31/    00            A I
A61K  31/    05            A I
A61K   9/    00            A I
A61P  25/    22            A I
A61K  47/    14            A I
A61K   9/    08            A I
A61K   9/   107            A I
Claims: number: 1
text: Cannabidiol (CBD) for its use in a method for treating anxiety or an anxiety-related disorder in an animal subject, the method comprising administering an effective amount of to the animal subject.
number: 2
text: Cannabidiol (CBD) for its use according to claim 1, during or subsequently to an anxiety-inducing situation.
number: 3
text: Cannabidiol (CBD) for its use according to claim 2, wherein the anxiety-inducing situation is a car ride.
number: 4
text: Cannabidiol (CBD) for its use according to claim 2, wherein the anxiety-inducing situation is a noise.
number: 5
text: Cannabidiol (CBD) for its use according to claim 4, wherein the noise is a loud noise, particularly a storm, more particularly a thunderstorm.
number: 6
text: Cannabidiol (CBD) for its use according to one of claims 1 to 5, wherein the animal subject is not a human subject.
number: 7
text: Cannabidiol (CBD) for its use according to claim 6, wherein the animal subject is a dog.
number: 8
text: Cannabidiol (CBD) for its use according to one of claims 1 to 7, wherein the effective amount is between about 0.1 mg/kg and about 100 mg/kg, particulalry between about 1 mg/kg and about 50 mg/kg, more particularly between about 1 mg/kg and about 25 mg/kg.
number: 9
text: Cannabidiol (CBD) for its use according to one of claims 1 to 8, wherein the CBD is administered orally.
number: 10
text: Cannabidiol (CBD) for its use according to claim 9, wherein the CBD is in a form suitable for the oral administration.
number: 11
text: Cannabidiol (CBD) for its use according to claim 10, wherein the CBD is mixed with a non-polar excipient.
number: 12
text: Cannabidiol (CBD) for its use according to claim 11, wherein the non-polar excipient includes a medium chain triglyceride.
number: 13
text: Cannabidiol (CBD) for its use according to one of claims 1 to 12, wherein the administration is carried out for at least 7 days.
number: 14
text: Cannabidiol (CBD) for its use according to one of claims 1 to 13, wherein the administration is carried out for at least 21 days.
number: 15
text: Cannabidiol (CBD) for its use according to one of claims 1 to 14, wherein the administration is carried out for at least 28 days.
Office action: search_report, dated 2020-10-07
Rejection reasons: novelty_epc_54
Prior art cited: ref_id: JP2018507262A
ref_type: patent
severity: background
ref_id: WO2016141056A1
ref_type: patent
severity: background
ref_id: WO2020102563A1
ref_type: patent
severity: background
ref_id: - LEBKOWSKA-WIERUSZEWSKA BEATA ET AL: "Pharmacokinetics of Bedrocan , a cannabis oil extract, in fasting and fed dogs: An explorative study", RESEARCH IN VETERINARY SCIENCE, vol. 123, 10 January 2019 (2019-01-10), pages 26 - 28, XP085632159, ISSN: 0034-5288, DOI: 10.1016/J.RVSC.2018.12.003
ref_type: npl
severity: background
ref_id: - LORI KOGAN ET AL: "US Veterinarians' Knowledge, Experience, and Perception Regarding the Use of Cannabidiol for Canine Medical Conditions", FRONTIERS IN VETERINARY SCIENCE, vol. 5, 10 January 2019 (2019-01-10), Lausanne, pages 338 - 1, XP055721813, ISSN: 2297-1769, DOI: 10.3389/fvets.2018.00338
ref_type: npl
severity: background
ref_id: WO2016141056
ref_type: patent
severity: novelty_destroying
ref_id: WO2020102563
ref_type: patent
severity: novelty_destroying
ref_id: - LEBKOWSKA-WIERUSZEWSKA BEATA ET AL, "Pharmacokinetics of Bedrocan , a cannabis oil extract, in fasting and fed dogs: An explorative study", RESEARCH IN VETERINARY SCIENCE, (20190110), vol. 123, doi:10.1016/J.RVSC.2018.12.003, ISSN 0034-5288, pages 26 - 28, XP085632159 [X] 1-10 * the whole document * [I] 11-15
ref_type: npl
severity: novelty_destroying
ref_id: - LORI KOGAN ET AL, "US Veterinarians' Knowledge, Experience, and Perception Regarding the Use of Cannabidiol for Canine Medical Conditions", FRONTIERS IN VETERINARY SCIENCE, Lausanne, (20190110), vol. 5, doi:10.3389/fvets.2018.00338, ISSN 2297-1769, pages 338 - 1, XP055721813 [X] 1-13 * the whole document * [I] 14,15
ref_type: npl
severity: novelty_destroying
Final disposition: pending (2020-10-07)